title: [Granulomatous hepatitis secondary to ingestion of carbamazepine. Report of a case].
abstract: A 51-year-old man with epilepsy received carbamazepine during three weeks. He developed fever, jaundice, dark urine and pale stools. Laboratory data showed hepatocellular injury and cholestasis; six weeks after withdrawal of the drug these abnormalities returned to normal limits. The liver biopsy showed acute cholangitis, bile duct injury, granulomas and eosinophils in the portal areas.
authors.forename: H
authors.initials: H
authors.lastname: Rodríguez Hernández
authors.forename: M
authors.initials: M
authors.lastname: Dehesa Violante
authors.forename: B
authors.initials: B
authors.lastname: Vega Ramos
authors.forename: T H
authors.initials: TH
authors.lastname: Méndez Gutiérrez
mesh_terms: D002220:Carbamazepine / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D002220:Carbamazepine
vernacular_title: Hepatitis granulomatosa secundaria a la ingestión de carbamazepina. Informe de un caso.